PetVivo Holdings, Inc. (PETV)
USD 0.63
(4.99%)
USD 0.63
(4.99%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.78 USD | 8.24% |
| 2023 | -0.85 USD | -51.79% |
| 2022 | -0.56 USD | 8.2% |
| 2021 | -0.61 USD | -511.84% |
| 2020 | -0.10 USD | 90.32% |
| 2019 | -1.03 USD | -68.85% |
| 2018 | -0.61 USD | 92.09% |
| 2017 | -7.71 USD | -272.46% |
| 2016 | -2.07 USD | -127.47% |
| 2015 | -0.91 USD | 99.71% |
| 2014 | -308.77 USD | -19820.65% |
| 2013 | -1.55 USD | 22.5% |
| 2012 | -2.00 USD | 65.87% |
| 2011 | -5.86 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 FY | - USD | 8.24% |
| 2024 Q1 | -0.25 USD | -13.64% |
| 2024 Q2 | -0.28 USD | -12.0% |
| 2024 Q4 | -0.19 USD | -58.33% |
| 2024 Q3 | -0.12 USD | 57.14% |
| 2023 Q4 | -0.22 USD | 4.35% |
| 2023 Q3 | -0.23 USD | -9.52% |
| 2023 Q2 | -0.21 USD | -5.0% |
| 2023 Q1 | -0.20 USD | -5.26% |
| 2023 FY | - USD | -51.79% |
| 2022 Q2 | -0.13 USD | -84.14% |
| 2022 FY | - USD | 8.2% |
| 2022 Q1 | -0.07 USD | -40.92% |
| 2022 Q3 | -0.17 USD | -30.77% |
| 2022 Q4 | -0.19 USD | -11.76% |
| 2021 Q2 | -0.23 USD | -43.75% |
| 2021 Q1 | -0.16 USD | -65.98% |
| 2021 FY | - USD | -511.84% |
| 2021 Q3 | -0.16 USD | 30.43% |
| 2021 Q4 | -0.05 USD | 68.69% |
| 2020 FY | - USD | 90.32% |
| 2020 Q1 | -0.10 USD | 64.29% |
| 2020 Q2 | -0.10 USD | 0.0% |
| 2020 Q3 | -0.10 USD | 0.2% |
| 2020 Q4 | -0.10 USD | 3.41% |
| 2019 Q1 | -0.48 USD | -92.0% |
| 2019 Q4 | -0.28 USD | -115.38% |
| 2019 Q3 | -0.13 USD | 18.75% |
| 2019 Q2 | -0.16 USD | 66.67% |
| 2019 FY | - USD | -68.85% |
| 2018 FY | - USD | 92.09% |
| 2018 Q4 | -0.25 USD | -78.57% |
| 2018 Q3 | -0.14 USD | -69.49% |
| 2018 Q1 | -0.15 USD | -360.12% |
| 2018 Q2 | -0.08 USD | 44.93% |
| 2017 FY | - USD | -272.46% |
| 2017 Q1 | -0.17 USD | 79.27% |
| 2017 Q4 | -0.03 USD | 76.71% |
| 2017 Q3 | -0.14 USD | 98.04% |
| 2017 Q2 | -7.13 USD | -4094.12% |
| 2016 Q1 | -0.80 USD | -138.83% |
| 2016 FY | - USD | -127.47% |
| 2016 Q4 | -0.82 USD | -272.73% |
| 2016 Q3 | -0.22 USD | 12.0% |
| 2016 Q2 | -0.25 USD | 68.75% |
| 2015 Q2 | -0.53 USD | -1.92% |
| 2015 Q1 | -0.52 USD | -533.33% |
| 2015 FY | - USD | 99.71% |
| 2015 Q3 | -8.79 USD | -1558.49% |
| 2015 Q4 | 2.06 USD | 123.44% |
| 2014 Q4 | 0.12 USD | 106.59% |
| 2014 Q3 | -1.82 USD | 89.15% |
| 2014 Q2 | -16.77 USD | -5140.63% |
| 2014 FY | - USD | -19820.65% |
| 2014 Q1 | -0.32 USD | -52.38% |
| 2013 Q1 | -0.46 USD | 46.51% |
| 2013 Q2 | -0.50 USD | -8.7% |
| 2013 Q3 | -0.30 USD | 40.0% |
| 2013 Q4 | -0.21 USD | 30.0% |
| 2013 FY | - USD | 22.5% |
| 2012 Q3 | -0.46 USD | -64.29% |
| 2012 Q2 | -0.28 USD | 31.71% |
| 2012 Q1 | -0.41 USD | -488.24% |
| 2012 FY | - USD | 65.87% |
| 2012 Q4 | -0.86 USD | -86.96% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | -1.21 USD | 0.0% |
| 2011 Q2 | -0.94 USD | 22.31% |
| 2011 Q3 | -0.71 USD | 24.47% |
| 2011 Q4 | -0.07 USD | 90.18% |
| Name | Eps | Eps Difference |
|---|---|---|
| Acutus Medical, Inc. | -2.81 USD | 72.242% |
| Biotricity, Inc. | -1.66 USD | 53.012% |
| Cell MedX Corp. | -0.00 USD | -155900.0% |
| Dynatronics Corporation | -1.00 USD | 22.0% |
| Nemaura Medical Inc. | -0.57 USD | -36.842% |
| RetinalGenix Technologies Inc. | -0.12 USD | -550.0% |
| Sonendo, Inc. | -0.65 USD | -20.0% |
| Telesis Bio, Inc. | -1.64 USD | 52.439% |
| Talis Biomedical Corporation | -34.12 USD | 97.714% |
| Viveve Medical, Inc. | -2.65 USD | 70.566% |